Gerd Burmester, MD

EULAR
Berlin, Germany

Senior Professor, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin

Presentation(s):

• 1332: Patient-Reported Outcomes, Disease Activity and Safety in 798 Patients with RA Treated with Filgotinib: Up to 1-Year Interim Results from a Prospective Observational Study (FILOSOPHY)

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.